In 2021, the Chinese Center for Drug Evaluation of the National Medical Products Administration (NMPA) approved 1,310 Investigational New Drug (IND) applications of chemical drugs. Almost half of all approvals were granted to antineoplastic drugs. A considerable number of drugs treating skin diseases, Ear, Nose and Throat (ENT) disorders, circulatory diseases, and digestive system conditions were also approved for general use.
Distribution of therapeutic areas for approved chemical drug Investigational New Drug (IND) applications in China in 2021
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
National Medical Products Administration. (June 1, 2022). Distribution of therapeutic areas for approved chemical drug Investigational New Drug (IND) applications in China in 2021 [Graph]. In Statista. Retrieved November 21, 2024, from https://www.statista.com/statistics/1319962/china-therapeutic-for-approved-chemical-drug-ind-applications/
National Medical Products Administration. "Distribution of therapeutic areas for approved chemical drug Investigational New Drug (IND) applications in China in 2021." Chart. June 1, 2022. Statista. Accessed November 21, 2024. https://www.statista.com/statistics/1319962/china-therapeutic-for-approved-chemical-drug-ind-applications/
National Medical Products Administration. (2022). Distribution of therapeutic areas for approved chemical drug Investigational New Drug (IND) applications in China in 2021. Statista. Statista Inc.. Accessed: November 21, 2024. https://www.statista.com/statistics/1319962/china-therapeutic-for-approved-chemical-drug-ind-applications/
National Medical Products Administration. "Distribution of Therapeutic Areas for Approved Chemical Drug Investigational New Drug (Ind) Applications in China in 2021." Statista, Statista Inc., 1 Jun 2022, https://www.statista.com/statistics/1319962/china-therapeutic-for-approved-chemical-drug-ind-applications/
National Medical Products Administration, Distribution of therapeutic areas for approved chemical drug Investigational New Drug (IND) applications in China in 2021 Statista, https://www.statista.com/statistics/1319962/china-therapeutic-for-approved-chemical-drug-ind-applications/ (last visited November 21, 2024)
Distribution of therapeutic areas for approved chemical drug Investigational New Drug (IND) applications in China in 2021 [Graph], National Medical Products Administration, June 1, 2022. [Online]. Available: https://www.statista.com/statistics/1319962/china-therapeutic-for-approved-chemical-drug-ind-applications/
